Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Desensitization and Tachyphylaxis

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...

Hypersensitivity Reactions: Cytolytic Reactions

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...

Cytotoxic Edema: Pathophysiology

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy and Safety of Interferon-Gamma in Chronic Granulomatous Disease: a Systematic Review and Meta-analysis.

Journal of clinical immunology·2022

Same author

Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.

Journal of clinical immunology·2022

Same author

Latin American consensus on the supportive management of patients with severe combined immunodeficiency.

The Journal of allergy and clinical immunology·2019

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

[Etoposide desensitization. A case report].

Aristóteles Alvarez Cardona¹, Leticia Hernández Nieto, Martín Pérez Gómez

¹Instituto Nacional de Pediatria, Insurgentes sur 3700-C, colonia Insurgentes Cuicuilco, CP 04530, DF Mexico. dr.aristoteles@yahoo.com.mx

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

|September 23, 2010

Summary

Severe hypersensitivity reactions to etoposide in a child with acute lymphoblastic leukemia were successfully managed using a 12-step desensitization protocol. This allowed for continued outpatient chemotherapy administration without further allergic events.

More Related Videos

Detection of DNA Double-Stranded Breaks in Mouse Oocytes

Detection of DNA Double-Stranded Breaks in Mouse Oocytes

Published on: June 23, 2023

Related Experiment Videos

Last Updated: Jun 8, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

Detection of DNA Double-Stranded Breaks in Mouse Oocytes

Detection of DNA Double-Stranded Breaks in Mouse Oocytes

Published on: June 23, 2023

Area of Science:

Oncology
Clinical Pharmacology
Immunology

Background:

Chemotherapeutic agents, including epipodophyllotoxins like etoposide, can cause hypersensitivity reactions (HSRs).
Repeated drug administration can increase sensitization, posing challenges in cancer treatment.
Etoposide is a critical drug for treating various cancers, including acute lymphoblastic leukemia (ALL).

Observation:

An 8-year-old male with high-risk ALL experienced mild HSRs to etoposide, requiring premedication.
Despite premedication and slow infusion, the patient developed severe HSRs (urticaria, angioedema, hypotension) during the second treatment course.
These severe reactions necessitated a specialized desensitization approach.

Findings:

A 12-step etoposide desensitization protocol was implemented.
Successful desensitization was achieved in the second round of the protocol.
Subsequent etoposide doses were administered in an ambulatory setting without recurrence of HSRs.

Implications:

Etoposide desensitization is a viable strategy for managing HSRs in pediatric cancer patients.
This protocol enables continued essential chemotherapy, improving treatment adherence and outcomes.
Successful desensitization facilitates outpatient management, potentially reducing healthcare costs and improving patient quality of life.